(PCRX) Pacira Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Pacira Pharmaceuticals | (PCRX) share price targets
Complete technical analysis of Pacira Pharmaceuticals (PCRX) by charts plus indicators, forecast predictions and share price targets for Pacira Pharmaceuticals (PCRX)
Pacira Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Pacira Pharmaceuticals is 1328886
| Date | Daily Closing Price | Open | High | Low | Volume |
| 23 Fri Jan 2026 | 20.67 | 20.73 | 21.08 | 20.40 | 0.549 times |
| 22 Thu Jan 2026 | 20.77 | 20.15 | 21.12 | 20.15 | 0.762 times |
| 21 Wed Jan 2026 | 20.24 | 19.30 | 20.25 | 19.27 | 1.046 times |
| 20 Tue Jan 2026 | 19.30 | 19.12 | 19.85 | 18.80 | 0.95 times |
| 16 Fri Jan 2026 | 19.16 | 20.51 | 20.84 | 18.92 | 0.893 times |
| 15 Thu Jan 2026 | 20.65 | 22.35 | 22.56 | 20.50 | 1.87 times |
| 14 Wed Jan 2026 | 22.24 | 21.64 | 22.53 | 21.35 | 0.776 times |
| 13 Tue Jan 2026 | 21.60 | 22.91 | 22.95 | 21.54 | 0.745 times |
| 12 Mon Jan 2026 | 22.93 | 23.66 | 23.85 | 22.79 | 0.501 times |
| 09 Fri Jan 2026 | 23.53 | 24.64 | 24.91 | 22.51 | 1.837 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 20.9, but if it comes above 20.9, then a intra day buy could be more profitable.
If you take a sell trade below 20.9, then use 20.9 as stoploss and 17.8 as target. However if you take a buy trade in stock , then use 20.9 as stoploss and 23.43 as target.
Share price targets for Pacira Pharmaceuticals (PCRX)
| Target Type | Value |
| Downside Target | 18.80 |
| Downside Target | 19.84 |
| Downside Target | 20.32 |
| Upside Target | 21.12 |
| Upside Target | 22.51 |
| Upside Target | 23.29 |
| Upside Target | 23.85 |
| Upside Target | 25.56 |
| Upside Target | 26.48 |
| Upside Target | 26.81 |
| Upside Target | 26.99 |
| Upside Target | 27.16 |
| Upside Target | 27.64 |
Intraday share price targets for Pacira Pharmaceuticals (PCRX)
| Target Type | Value |
| Downside Intraday Target | 19.27 |
| Downside Intraday Target | 17.88 |
| Upside Intraday Target | 21.59 |
| Upside Intraday Target | 22.52 |
| Downside Intraday Target | 20.2 |
Weekly technical analysis of Pacira Pharmaceuticals (PCRX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 23 Fri Jan 2026 | 20.67 | 19.12 | 21.12 | 18.80 | 0.691 times |
| 16 Fri Jan 2026 | 19.16 | 23.66 | 23.85 | 18.92 | 1.079 times |
| 09 Fri Jan 2026 | 23.53 | 24.24 | 26.48 | 22.51 | 2.575 times |
| 02 Fri Jan 2026 | 24.46 | 26.51 | 26.81 | 24.20 | 1.049 times |
| 26 Fri Dec 2025 | 26.51 | 26.20 | 26.99 | 25.56 | 0.335 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Pacira Pharmaceuticals (PCRX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 23 Fri Jan 2026 | 20.67 | 26.07 | 26.81 | 18.80 | 0.946 times |
| 31 Wed Dec 2025 | 25.88 | 23.49 | 27.16 | 23.29 | 1.324 times |
| 28 Fri Nov 2025 | 23.57 | 21.78 | 24.95 | 20.32 | 1.111 times |
| 31 Fri Oct 2025 | 21.38 | 25.80 | 26.05 | 19.84 | 1.021 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Pacira Pharmaceuticals (PCRX)
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Pacira Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Pacira Pharmaceuticals in short term and the sell signal is strong.
Pacira Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Pacira Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Pacira Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 21.2 and Pacira Pharmaceuticals (PCRX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Pacira Pharmaceuticals (PCRX) stock. Volume based technical analysis of Pacira Pharmaceuticals (PCRX) stock is negative.
Pacira Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Pacira Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Pacira Pharmaceuticals in short term and the sell signal is strong.
Pacira Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Pacira Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Pacira Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 21.2 and Pacira Pharmaceuticals (PCRX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Pacira Pharmaceuticals (PCRX) stock. Volume based technical analysis of Pacira Pharmaceuticals (PCRX) stock is negative.
Pacira Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

